• The Doctors Company completed its acquisition of ProAssurance, buying all outstanding shares for USD 25 per share in cash.
• The deal values ProAssurance at about USD 1.3 billion.
• ProAssurance will operate as a wholly owned subsidiary while the group reviews its long-term operating structure.
• ProAssurance stock was deregistered with the SEC, delisted from the NYSE; public trading has ceased.
• The combined group expects to cover more than 200,000 healthcare professionals and organizations, backed by USD 12 billion in assets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProAssurance Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606260915PR_NEWS_USPR_____LA93171) on June 26, 2026, and is solely responsible for the information contained therein.